Copyright
©The Author(s) 2021.
World J Gastroenterol. Dec 21, 2021; 27(47): 8081-8102
Published online Dec 21, 2021. doi: 10.3748/wjg.v27.i47.8081
Published online Dec 21, 2021. doi: 10.3748/wjg.v27.i47.8081
Figure 1 The main therapeutic targets and the drugs under development for hepatitis B.
HBV: Hepatitis B virus; HBsAg: Hepatitis B surface antigen; HBeAg: Hepatitis B e antigen; cccDNA: Covalently closed circular DNA.
Figure 2 Shows the timeline of antiviral treatment for hepatitis C virus.
HCV: Hepatitis C virus; IFN: Interferon; RBV: Ribavirin; Peg: Pegylated; DAA: Direct-acting antiviral; WHO: World Health Organization.
Figure 3 Proposals for the management of hepatitis C.
MSM: Men who have sex with men; SMD: Severe mental disorder; Ag: Antigen; HCV: Hepatitis C virus; NGO: Non-governmental organization.
- Citation: González Grande R, Santaella Leiva I, López Ortega S, Jiménez Pérez M. Present and future management of viral hepatitis. World J Gastroenterol 2021; 27(47): 8081-8102
- URL: https://www.wjgnet.com/1007-9327/full/v27/i47/8081.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i47.8081